Skip to main content
British Medical Journal logoLink to British Medical Journal
. 1975 Mar 15;1(5958):590–591.

Editorial: Sézary syndrome.

PMCID: PMC1672813  PMID: 123808

Full text

PDF
590

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Crossen P. E., Mellor J. E., Finley A. G., Ravich R. B., Vincent P. C., Gunz F. W. The Sézary syndrome: cytogenetic studies and identification of the Sézary Cell as an abnormal lymphocyte. Am J Med. 1971 Jan;50(1):24–34. doi: 10.1016/0002-9343(71)90201-4. [DOI] [PubMed] [Google Scholar]
  2. Edelson R., Facktor M., Andrews A., Lutzner M., Schein P. Successful management of the Sézary syndrome. Mobilization and removal of extravascular neoplastic T cells by leukapheresis. N Engl J Med. 1974 Aug 8;291(6):293–294. doi: 10.1056/NEJM197408082910608. [DOI] [PubMed] [Google Scholar]
  3. Flandrin G., Daniel M. T. Beta-glucuronidase activity in Sezary cells. Scand J Haematol. 1974;12(1):23–31. doi: 10.1111/j.1600-0609.1974.tb00176.x. [DOI] [PubMed] [Google Scholar]
  4. Prunieras M. DNA content and cytogenetics of the Sezary cell. Mayo Clin Proc. 1974 Aug;49(8):548–552. [PubMed] [Google Scholar]
  5. Winkelmann R. K. Clinical studies of T-cell erythroderma in the Sezary syndrome. Mayo Clin Proc. 1974 Aug;49(8):519–525. [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES